Evommune, Inc. carries a market capitalization of 280.74M, placing it among publicly traded companies globally.
| Market Cap | 280.74M |
| Enterprise Value | N/A |
Evommune, Inc.'s stock has declined approximately -2.02669% over the past 52 weeks. The 50-day moving average sits at 24.12, while the 200-day moving average is 22.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -2.02669% |
| 50-Day Moving Average | 24.12 |
| 200-Day Moving Average | 22.12 |
| Average Volume (20 Days) | N/A |